EUROMEDICA S.A.
Announcement
Euromedica Group sees spectacular increase in financial results over the first 9 months of 2007
After-tax revenues were over-doubled
The EBITDA revenues of Euromedica Group were ?42 million in the first 9 months of 2007, i.e. they were over-doubled compared to 19.8 million euros over the first 9 months of 2006.
The net pre-tax revenues of the Group were 26.5 millioneuros , an impressive increase of 173% compared to 9.7 million eurosover the first 9 months of 2006. The increase in after-tax revenues of the Group was even more spectacular, reaching ?18.1 million compared to ?5.5 in the first 9 months of 2006 (over-tripled). The consolidated turnover showed a rise of 21.6%, from 114.2 million euros to 138.8 million euros.
At a parent company level, the EBITDA revenues were almost over-tripled and amounted to ?25.9 million compared to ?8.7 million over the respective period of 2006.
The net pre-tax revenues reached 17.25 million eurosfrom 2.6 million euros in the first 9 months of 2006, while after-tax revenues reached 12.4 million euros from ?558 thousand in the respective period of the previous year. The corporate turn over was ?66.25 million, showing a rise of 6,5%.
The financial results of the Group and the Company for the first 9 months of 2007 were published on November 22nd, 2007 in the newspaper KERDOS. They were also published on the same day on the corporate website at www.euromedica.gr .
After-tax revenues were over-doubled
The EBITDA revenues of Euromedica Group were ?42 million in the first 9 months of 2007, i.e. they were over-doubled compared to 19.8 million euros over the first 9 months of 2006.
The net pre-tax revenues of the Group were 26.5 millioneuros , an impressive increase of 173% compared to 9.7 million eurosover the first 9 months of 2006. The increase in after-tax revenues of the Group was even more spectacular, reaching ?18.1 million compared to ?5.5 in the first 9 months of 2006 (over-tripled). The consolidated turnover showed a rise of 21.6%, from 114.2 million euros to 138.8 million euros.
At a parent company level, the EBITDA revenues were almost over-tripled and amounted to ?25.9 million compared to ?8.7 million over the respective period of 2006.
The net pre-tax revenues reached 17.25 million eurosfrom 2.6 million euros in the first 9 months of 2006, while after-tax revenues reached 12.4 million euros from ?558 thousand in the respective period of the previous year. The corporate turn over was ?66.25 million, showing a rise of 6,5%.
The financial results of the Group and the Company for the first 9 months of 2007 were published on November 22nd, 2007 in the newspaper KERDOS. They were also published on the same day on the corporate website at www.euromedica.gr .